Nagata C, Nakamura K, Wada K, Tsuji M, Tamai Y, Kawachi T. Branched-chain amino acid intake and the risk of diabetes in a Japanese community: the Takayama study. Am J Epidemiol. 2013;178(8):1226-32. View abstract.
Nakanishi K, Namisaki T, Mashitani T, et al. Late-evening snack with branched-chain amino acid-enriched nutrients does not always inhibit overt diabetes in patients with cirrhosis: A pilot study. Nutrients. 2019;11(9):2140. View abstract.
Naylor CD, O'Rourke K, Detsky AS, Baker JP. Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterology 1989;97:1033-42. View abstract.
Negro M, Giardina S, Marzani B, Marzatico F. Branched-chain amino acid supplementation does not enhance athletic performance but affects muscle recovery and the immune system. J Sports Med Phys Fitness 2008;48(3):347-51. View abstract.
Nojiri S, Fujiwara K, Shinkai N, Iio E, Joh T. Effects of branched-chain amino acid supplementation after radiofrequency ablation for hepatocellular carcinoma: A randomized trial. Nutrition. 2017;33:20-27. View abstract.
Novin ZS, Ghavamzadeh S, Mehdizadeh A. The Weight Loss Effects of Branched Chain Amino Acids and Vitamin B6: A Randomized Controlled Trial on Obese and Overweight Women. Int J Vitam Nutr Res. 2018;88(1-2):80-89. View abstract.
Nutt JG, Woodward WR, Hammerstad JP, et al. The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. N Engl J Med 1984;310:483-8. View abstract.
O'Keefe SJ, Ogden J, Dicker J. Enteral and parenteral branched chain amino acid-supplemented nutritional support in patients with encephalopathy due to alcoholic liver disease. JPEN J Parenter Enteral Nutr 1987;11:447-53. View abstract.
Okekunle AP, Wu X, Duan W, Feng R, Li Y, Sun C. Dietary Intakes of Branched-Chained Amino Acid and Risk for Type 2 Diabetes in Adults: The Harbin Cohort Study on Diet, Nutrition and Chronic Non-Communicable Diseases Study. Can J Diabetes. 2018;42(5):484-492.e7. View abstract.
Okekunle AP, Zhang M, Wang Z, et al. Dietary branched-chain amino acids intake exhibited a different relationship with type 2 diabetes and obesity risk: a meta-analysis. Acta Diabetol. 2019;56(2):187-195. View abstract.
Ooi DSQ, Ling JQR, Sadananthan SA, et al. Branched-Chain Amino Acid Supplementation Does Not Preserve Lean Mass or Affect Metabolic Profile in Adults with Overweight or Obesity in a Randomized Controlled Weight Loss Intervention. J Nutr. 2021;151(4):911-920. View abstract.
Park JG, Tak WY, Park SY, et al. Effects of branched-chain amino acid (BCAA) supplementation on the progression of advanced liver disease: A Korean nationwide, multicenter, prospective, observational, cohort Study. Nutrients. 2020;12(5):1429. View abstract.
Park MK, Lee SJ, Choi E, Lee S, Lee J. The Effect of Branched Chain Amino Acid Supplementation on Stroke-Related Sarcopenia. Front Neurol 2022;13:744945. View abstract.
Partin JF, Pushkin YR. Tachyarrhythmia and hypomania with horny goat weed. Psychosomatics 2004;45:536-7. View abstract.
Peng LN, Yu PC, Hsu CC, et al. Sarcojoint®, the branched-chain amino acid-based supplement, plus resistance exercise improved muscle mass in adults aged 50 years and older: A double-blinded randomized controlled trial. Exp Gerontol 2022;157:111644. View abstract.
Plaitakis A, Smith J, Mandeli J, Yahr MD. Pilot trial of branched-chain aminoacids in amyotrophic lateral sclerosis. Lancet 1988;1:1015-8. View abstract.
Plauth M, Egberts EH, Hamster W, et al. Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study. J Hepatol 1993;17:308-14. View abstract.
Proud CG. Regulation of mammalian translation factors by nutrients. Eur J Biochem 2002;269:5338-49.. View abstract.
Ra SG, Miyazaki T, Kojima R, et al. Effect of BCAA supplement timing on exercise-induced muscle soreness and damage: a pilot placebo-controlled double-blind study. J Sports Med Phys Fitness. 2018;58(11):1582-1591. View abstract.
Rahimi MH, Shab-Bidar S, Mollahosseini M, Djafarian K. Branched-chain amino acid supplementation and exercise-induced muscle damage in exercise recovery: A meta-analysis of randomized clinical trials. Nutrition. 2017;42:30-36. View abstract.
Richardson MA, Bevans ML, Read LL, et al. Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men. Am J Psychiatry 2003;160:1117-24.. View abstract.
Richardson MA, Bevans ML, Weber JB, et al. Branched chain amino acids decrease tardive dyskinesia symptoms. Psychopharmacology (Berl) 1999;143:358-64. View abstract.
Richardson MA, Small AM, Read LL, et al. Branched chain amino acid treatment of tardive dyskinesia in children and adolescents. J Clin Psychiatry 2004;65:92-6. View abstract.
Riordan SM, Williams R. Treatment of Hepatic Encephalopathy. N Engl J Med 1997;337:473-9.
Rosen HM, Yoshimura N, Hodgman JM, Fischer JE. Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology 1977;72:483-7. View abstract.
Rossi Fanelli F, Cangiano C, Capocaccia L, et al. Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences. Gut 1986;27:111-5. View abstract.
Rossi M, Mascaretti F, Parpinel M, et al. Dietary intake of branched-chain amino acids and colorectal cancer risk. Br J Nutr. 2020:1-6. View abstract.
Rossi M, Turati F, Strikoudi P, et al. Dietary intake of branched-chain amino acids and pancreatic cancer risk in a case-control study from Italy. Br J Nutr 2022. View abstract.
Saben JL, Sims CR, Pack L, Lan R, Børsheim E, Andres A. Infant intakes of human milk branched chain amino acids are negatively associated with infant growth and influenced by maternal body mass index. Pediatr Obes 2022;17(5):e12876. View abstract.
Scarna A, Gijsman HJ, McTavish SF, et al. Effects of a branched-chain amino acid drink in mania. Br J Psychiatry 2003;182:210-3.. View abstract.
Shimomura Y, Murakami T, Nakai N, Nagasaki M, Harris RA. Exercise promotes BCAA catabolism: effects of BCAA supplementation on skeletal muscle during exercise. J Nutr 2004;134(6 Suppl):1583S-1587S. View abstract.
Shimomura Y, Yamamoto Y, Bajotto G, et al. Nutraceutical effects of branched-chain amino acids on skeletal muscle. J Nutr 2006;136(2):529S-532S. View abstract.
Singh Tejavath A, Mathur A, Nathiya D, et al. Impact of Branched Chain Amino Acid on Muscle Mass, Muscle Strength, Physical Performance, Combined Survival, and Maintenance of Liver Function Changes in Laboratory and Prognostic Markers on Sarcopenic Patients With Liver Cirrhosis (BCAAS Study): A Randomized Clinical Trial. Front Nutr 2021;8:715795. View abstract.
Stein TP, Schluter MD, Leskiw MJ, Boden G. Attenuation of the protein wasting associated with bed rest by branched-chain amino acids. Nutrition 1999;15:656-60. View abstract.
Suryawan A, Hawes JW, Harris RA, et al. A molecular model of human branched-chain amino acid metabolism. Am J Clin Nutr 1998;68:72-81. View abstract.
Takeuchi I, Yoshimura Y, Shimazu S, Jeong S, Yamaga M, Koga H. Effects of branched-chain amino acids and vitamin D supplementation on physical function, muscle mass and strength, and nutritional status in sarcopenic older adults undergoing hospital-based rehabilitation: A multicenter randomized controlled trial. Geriatr Gerontol Int. 2019;19(1):12-17. View abstract.
Tandan R, Bromberg MB, Forshew D, et al. A controlled trial of amino acid therapy in amyotrophic lateral sclerosis: I. Clinical, functional, and maximum isometric torque data. Neurology 1996;47:1220-6. View abstract.
Testa D, Caraceni T, Fetoni V. Branched-chain amino acids in the treatment of amyotrophic lateral sclerosis. J Neurol 1989;236:445-7. View abstract.
To CY, Freeman M, Van Winkle LJ. Consumption of a branched-chain amino acid (BCAA) during days 2-10 of pregnancy causes abnormal fetal and placental growth: Implications for BCAA supplementation in humans. Int J Environ Res Public Health. 2020;17(7):2445. View abstract.
Tynkkynen J, Chouraki V, van der Lee SJ, et al. Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study in eight cohorts. Alzheimers Dement. 2018;14(6):723-733. View abstract.
Uchino Y, Watanabe M, Takata M, et al. Effect of Oral Branched-Chain Amino Acids on Serum Albumin Concentration in Heart Failure Patients with Hypoalbuminemia: Results of a Preliminary Study. Am J Cardiovasc Drugs. 2018;18(4):327-332. View abstract.
Anonymous. Evening primrose hypertension hope. Central 1989;35
Anstey, A. Quigley M. Wilkinson J. D. Topical evening primrose oil as treatment for atopic eczema. J dermatol treat. 1990;1(4):199-201.
Aragona, P., Bucolo, C., Spinella, R., Giuffrida, S., and Ferreri, G. Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjogren's syndrome patients. Invest Ophthalmol.Vis.Sci 2005;46(12):4474-4479. View abstract.
Arisaka, M., Arisaka, O., and Yamashiro, Y. Fatty acid and prostaglandin metabolism in children with diabetes mellitus. II. The effect of evening primrose oil supplementation on serum fatty acid and plasma prostaglandin levels. Prostaglandins Leukot.Essent.Fatty Acids 1991;43(3):197-201. View abstract.
Bamford, J. T., Gibson, R. W., and Renier, C. M. Atopic eczema unresponsive to evening primrose oil (linoleic and gamma- linolenic acids). J Am.Acad.Dermatol. 1985;13(6):959-965. View abstract.
Barabino, S., Rolando, M., Camicione, P., Ravera, G., Zanardi, S., Giuffrida, S., and Calabria, G. Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea 2003;22(2):97-101. View abstract.
Barber A. Evening primrose oil: a panacea? Pharmaceutical J 1988;723-725.
Bates D, Fawcett PRW, Shaw DA, and et all. Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis. Br Med J 1978;ii:1390-1391.
Bayles, B. and Usatine, R. Evening primrose oil. Am Fam.Physician 12-15-2009;80(12):1405-1408. View abstract.
Berth-Jones, J., Thompson, J., and Graham-Brown, R. A. Evening primrose oil and atopic eczema. Lancet 2-25-1995;345(8948):520. View abstract.
Biagi, P. L., Bordoni, A., Masi, M., Ricci, G., Fanelli, C., Patrizi, A., and Ceccolini, E. A long-term study on the use of evening primrose oil (Efamol) in atopic children. Drugs Exp Clin Res 1988;14(4):285-290. View abstract.
Boehm, K. Pittler M. H. Wilson N. van Gool C. Humphreys R. Ernst E. Oral evening primrose oil and borage oil for atopic eczema. Cochrane Database Sys Rev 2009;(1):CD004416.
Callender K, McGregor M, and Kirk P. A double-blind trial of evening primrose oil in the premenstrual syndrome: nervous symptom subgroup. Hum Psychopharmacol 1988;3:57-61.
Cameron, M., Gagnier, J. J., and Chrubasik, S. Herbal therapy for treating rheumatoid arthritis. Cochrane Database Syst.Rev. 2011;(2):CD002948. View abstract.
Cameron, M., Gagnier, J. J., Little, C. V., Parsons, T. J., Blumle, A., and Chrubasik, S. Evidence of effectiveness of herbal medicinal products in the treatment of arthritis. Part 2: Rheumatoid arthritis. Phytother.Res 2009;23(12):1647-1662. View abstract.
Centre for Reivews and Dissemination.
Centre for Reviews and Dissemination. Oral essential fatty acid supplementation in atopic dermatitis: a meta-analysis of placebo-controlled trials (Structured abstract). 2012;3
Chilton, S. A. Cognitive behaviour therapy for the chronic fatigue syndrome. Evening primrose oil and magnesium have been shown to be effective. BMJ 4-27-1996;312(7038):1096. View abstract.
Conquer, J. A., Roelfsema, H., Zecevic, J., Graham, T. E., and Holub, B. J. Effect of exercise on FA profiles in n-3 FA-supplemented and -nonsupplemented premenopausal women. Lipids 2002;37(10):947-951. View abstract.
Coskery G, Cowley N Allen R. The effect of dietary supplementation with evening primrose oil on skin surface texture in atopic dermatitis. J Investigative Dermatitis 1988;91(4):413.
el Ela, S. H., Prasse, K. W., Carroll, R., and Bunce, O. R. Effects of dietary primrose oil on mammary tumorigenesis induced by 7,12-dimethylbenz(a)anthracene. Lipids 1987;22(12):1041-1044. View abstract.
Endres, S., Lorenz, R., and Loeschke, K. Lipid treatment of inflammatory bowel disease. Curr Opin.Clin Nutr Metab Care 1999;2(2):117-120. View abstract.
Engler MM. The hypotensive effect of dietary gamma-linolenic acid and associated alterations in tissue fatty acid composition and the Renin-Angiotensin system. Abstracts from the International Symposium on Gamma Linolenic Acid, American Oil Chemists Society, Health and Nutrition Division Annual Conference, San Diego, CA, 2000.
Engler, M. M. Comparative study of diets enriched with evening primrose, black currant, borage or fungal oils on blood pressure and pressor responses in spontaneously hypertensive rats. Prostaglandins Leukot.Essent.Fatty Acids 1993;49(4):809-814. View abstract.
Engler, M. M., Schambelan, M., Engler, M. B., Ball, D. L., and Goodfriend, T. L. Effects of dietary gamma-linolenic acid on blood pressure and adrenal angiotensin receptors in hypertensive rats. Proc.Soc.Exp.Biol.Med. 1998;218(3):234-237. View abstract.
Ferrando, J. [Clinical trial of a topical preparation containing urea, sunflower oil, evening primrose oil, wheat germ oil and sodium pyruvate, in several hyperkeratotic skin conditions]. Med Cutan.Ibero.Lat.Am 1986;14(2):133-137. View abstract.
Ferreira MJ, Fiadeiro T Silva M Soares AP. Topical gamma-linolenic acid therapy in atopic dermatitis: a clinical and biometric evaluation. Allergo J 1998;7(4):213-216.
Field, E. J. and Joyce, G. Effect of prolonged ingestion of gamma-linolenate by MS patients. Eur.Neurol. 1978;17(2):67-76. View abstract.
Garcia C, Carter J, and Chou A. Gamma linolenic acid causes weight loss and lower blood pressure in overweight patients with family history of obesity. Swed J Biol Med 1986;4:8-11.
Gateley, C. A. and Mansel, R. E. Management of cyclical breast pain. Br.J Hosp.Med 1990;43(5):330-332. View abstract.
Gateley, C. A. and Mansel, R. E. Management of the painful and nodular breast. Br Med Bull. 1991;47(2):284-294. View abstract.
Gateley, C. A., Maddox, P. R., Mansel, R. E., and Hughes, L. E. Mastalgia refractory to drug treatment. Br J Surg. 1990;77(10):1110-1112. View abstract.
Gateley, C. A., Maddox, P. R., Pritchard, G. A., Sheridan, W., Harrison, B. J., Pye, J. K., Webster, D. J., Hughes, L. E., and Mansel, R. E. Plasma fatty acid profiles in benign breast disorders. Br J Surg. 1992;79(5):407-409. View abstract.
Gateley, C. A., Miers, M., Mansel, R. E., and Hughes, L. E. Drug treatments for mastalgia: 17 years experience in the Cardiff Mastalgia Clinic. J R.Soc Med 1992;85(1):12-15. View abstract.
Gimenes, O. M., da Silva, M. J., and Benko, M. A. [Flower essences: vibrational intervention of diagnostic and therapeutic possibilities]. Rev.Esc Enferm.USP. 2004;38(4):386-395. View abstract.
Goodwin, P. J., Neelam, M., and Boyd, N. F. Cyclical mastopathy: a critical review of therapy. Br.J Surg. 1988;75(9):837-844. View abstract.
Goyal, A. and Mansel, R. E. A randomized multicenter study of gamolenic acid (Efamast) with and without antioxidant vitamins and minerals in the management of mastalgia. Breast J 2005;11(1):41-47. View abstract.
Greaves, M. W. and Corbett, M. F. Treatment of atopic eczema with evening primrose oil. Br.J Dermatol. 1988;118(3):449-451. View abstract.
Gruenwald, J., Graubaum, H. J., and Busch, R. Efficacy and tolerability of a fixed combination of thyme and primrose root in patients with acute bronchitis. A double-blind, randomized, placebo-controlled clinical trial. Arzneimittelforschung 2005;55(11):669-676. View abstract.
Gruenwald, J., Graubaum, H. J., and Busch, R. Evaluation of the non-inferiority of a fixed combination of thyme fluid- and primrose root extract in comparison to a fixed combination of thyme fluid extract and primrose root tincture in patients with acute bronchitis. A single-blind, randomized, bi-centric clinical trial. Arzneimittelforschung 2006;56(8):574-581. View abstract.
Guenther, L. and Wexler, D. Efamol in the treatment of atopic dermatitis. J Am Acad.Dermatol. 1987;17(5 Pt 1):860. View abstract.
Halat, K. M. and Dennehy, C. E. Botanicals and dietary supplements in diabetic peripheral neuropathy. J Am Board Fam.Pract. 2003;16(1):47-57. View abstract.
Horrobin, D. F. and Morse, P. F. Evening primrose oil and atopic eczema. Lancet 1-28-1995;345(8944):260-261. View abstract.
Horrobin, D. F. and Stewart, C. Evening primrose oil and atopic eczema. Lancet 7-7-1990;336(8706):50. View abstract.
Horrobin, D. F. and Stewart, C. Evening primrose oil in atopic eczema. Lancet 4-7-1990;335(8693):864-865. View abstract.
Horrobin, D. F. Essential fatty acid and prostaglandin metabolism in Sjogren's syndrome, systemic sclerosis and rheumatoid arthritis. Scand.J Rheumatol.Suppl 1986;61:242-245. View abstract.
Horrobin, D. F. Multiple sclerosis: the rational basis for treatment with colchicine and evening primrose oil. Med Hypotheses 1979;5(3):365-378. View abstract.
Horrobin, D. F. The importance of gamma-linolenic acid and prostaglandin E1 in human nutrition and medicine. Journal of Holistic Medicine. 1981;3(2):118-139.
Hounsom, L., Horrobin, D. F., Tritschler, H., Corder, R., and Tomlinson, D. R. A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy. Diabetologia 1998;41(7):839-843. View abstract.
Humphreys F, Symons J, Brown H, and et al. The effects of gamolenic acid on adult atopic eczema and premenstrual exacerbation of eczema. Eur.J.Dermatol. 1994;4(598):603.
Jamal, G. A., Carmichael, H., and Weir, A. I. Gamma-linolenic acid in diabetic neuropathy. Lancet 5-10-1986;1(8489):1098. View abstract.
Jantti, J., Nikkari, T., Solakivi, T., Vapaatalo, H., and Isomaki, H. Evening primrose oil in rheumatoid arthritis: changes in serum lipids and fatty acids. Ann.Rheum.Dis 1989;48(2):124-127. View abstract.
Jaszewska, E., Kosmider, A., Kiss, A. K., and Naruszewicz, M. Oenothera paradoxa defatted seeds extract containing pentagalloylglucose and procyanidins potentiates the cytotoxicity of vincristine. J Physiol Pharmacol 2010;61(5):637-643. View abstract.
Joe, L. A. and Hart, L. L. Evening primrose oil in rheumatoid arthritis. Ann.Pharmacother. 1993;27(12):1475-1477. View abstract.
Johnson, M., Ostlund, S., Fransson, G., Kadesjo, B., and Gillberg, C. Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents. J.Atten.Disord. 2009;12(5):394-401. View abstract.
Jones, L. Essential Fatty Acids and Dry Eye: What Do We Know? Contact Lens Spectrum 2009;24(7):14-15.
Kemmerich, B. Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled multicentre clinical trial. Arzneimittelforschung 2007;57(9):607-615. View abstract.
Kiehl R, Ionescu G, Manuel P, and et al. Klinische, immun- und lipidmodulatorische effekte einer behandlung mit ungesattigten fettsauren bei atopischer dermatitis. Med.Leiter: J.Muller-Steinwachs 1994;69(1):42-48.
Kiss, A. K., Filipek, A., Czerwinska, M., and Naruszewicz, M. Oenothera paradoxa defatted seeds extract and its bioactive component penta-O-galloyl-beta-D-glucose decreased production of reactive oxygen species and inhibited release of leukotriene B4, interleukin-8, elastase, and myeloperoxidase in human neutrophils. J Agric.Food Chem 9-22-2010;58(18):9960-9966. View abstract.
Kruger, M. C., Coetzer, H., de Winter, R., Gericke, G., and van Papendorp, D. H. Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging (Milano.) 1998;10(5):385-394.
Langmead, L., Chitnis, M., and Rampton, D. S. Use of complementary therapies by patients with IBD may indicate psychosocial distress. Inflamm.Bowel.Dis 2002;8(3):174-179. View abstract.
Liu, H. and Zhou, J. F. [Xianbai buyang Huanwu decoction used for treating hypertension with kidney qi deficiency and blood stasis]. Zhongguo Zhong Xi Yi Jie He Za Zhi 1993;13(12):714-7, 707. View abstract.
Liu, L. Z. Wu Q. Liu P. J. Li G. Q. Bensoussan A. Kiat H. Chinese herbal medicines for hypertriglyceridemia. Cochrane Database Sys Rev 2012;(1):CD009560.
Manku, M. S., Horrobin, D. F., Morse, N., Kyte, V., Jenkins, K., Wright, S., and Burton, J. L. Reduced levels of prostaglandin precursors in the blood of atopic patients: defective delta-6-desaturase function as a biochemical basis for atopy. Prostaglandins Leukot.Med 1982;9(6):615-628. View abstract.
Mansel RE, Pye JK Hughes LE. Effects of essential fatty acids on cyclical mastalgia and non-cyclical breast disorders. In: Horrobin DF. Omega-6 essential fatty acids: pathophysiology and roles in clinical medicine. New York: Wiley-Liss;1990.
Mansel, R. E., Harrison, B. J., Melhuish, J., Sheridan, W., Pye, J. K., Pritchard, G., Maddox, P. R., Webster, D. J., and Hughes, L. E. A randomized trial of dietary intervention with essential fatty acids in patients with categorized cysts. Ann.N.Y.Acad.Sci. 1990;586:288-294. View abstract.
Martens-Lobenhoffer, J. and Meyer, F. P. Pharmacokinetic data of gamma-linolenic acid in healthy volunteers after the administration of evening primrose oil (Epogam). Int.J Clin Pharmacol Ther. 1998;36(7):363-366. View abstract.
McFayden, I. J., Forrest, A. P., Chetty, U., and Raab, G. Cyclical breast pain--some observations and the difficulties in treatment. Br.J Clin Pract. 1992;46(3):161-164. View abstract.
Meigel, W., Dettke, T., Meigel, E. M., and Lenze, U. [Additional oral therapy of atopic dermatitis with unsaturated fatty acids]. Z.Hautkr. 1987;62 Suppl 1:100-103. View abstract.
Murray, T., Kelsberg, G., Safranek, S., and Crawford, P. Clinical inquiries. Do any folk remedies or herbals help induce labor? J Fam.Pract. 2008;57(8):542-544. View abstract.
Namaka, M., Crook, A., Doupe, A., Kler, K., Vasconcelos, M., Klowak, M., Gong, Y., Wojewnik-Smith, A., and Melanson, M. Examining the evidence: complementary adjunctive therapies for multiple sclerosis. Neurol.Res 2008;30(7):710-719. View abstract.
Newman, V., Rock, C. L., Faerber, S., Flatt, S. W., Wright, F. A., and Pierce, J. P. Dietary supplement use by women at risk for breast cancer recurrence. The Women's Healthy Eating and Living Study Group. J Am Diet.Assoc. 1998;98(3):285-292. View abstract.
Ockerman PA, Bachrack I, Glans S, and et al. Evening primrose oil as a treatment of premenstrual syndrome. Rec Adv Clin Nutr 1986;2:404-405.
Olsson, R., Tysk, C., Aldenborg, F., and Holm, B. Prolonged postpartum course of intrahepatic cholestasis of pregnancy. Gastroenterology 1993;105(1):267-271. View abstract.
Papas, E. Mcoptom D. Dry Eye and Diet: What Research Says About Essential Fatty Acids. Contact Lens Spectrum. 2012;27(3):16-17.
Parveen, S. Sarwar G. Ali M. Channa G. A. Danazol versus oil of evening primrose in the treatment of mastalgia. Pakistan Journal of Surgery. 2007;23(1):10-13.
Pashby N, Mansel R, Hughes L, and et al. A clinical trial of evening primrose in mastalgia. Br J Surg 1981;68:801.
Pellegrina, C. D., Padovani, G., Mainente, F., Zoccatelli, G., Bissoli, G., Mosconi, S., Veneri, G., Peruffo, A., Andrighetto, G., Rizzi, C., and Chignola, R. Anti-tumour potential of a gallic acid-containing phenolic fraction from Oenothera biennis. Cancer Lett. 8-8-2005;226(1):17-25. View abstract.
Platzbecker, U., Aul, C., Ehninger, G., and Giagounidis, A. Reduction of 5-azacitidine induced skin reactions in MDS patients with evening primrose oil. Ann Hematol. 2010;89(4):427-428. View abstract.
Poisson J, Germain-Bellenger S, Engler M, and et al. Gamma-linolenic acid: A pharmacological nutrient for hypertension? Abstracts from the International Symposium on Gamma Linolenic Acid, American Oil Chemists Society, Health and Nutrition Division Annual Conference, San Diego, CA, 2000.
Preece PE, Hanslip JI Gilbert L. Evening primrose oil (Efamol) for mastalgia. In: Horrobin DF. Clinical Uses of Essential Fatty Acids . Montreal, Quebec: Eden;1982.
Qureshi, S. and Sultan, N. Topical nonsteroidal anti-inflammatory drugs versus oil of evening primrose in the treatment of mastalgia. Surgeon. 2005;3(1):7-10. View abstract.
Ring, J. and Kleinheinz, A. [Evening primrose oil in neurodermatitis?]. Med Monatsschr.Pharm. 1991;14(9):282. View abstract.
Rosolowich, V., Saettler, E., Szuck, B., Lea, R. H., Levesque, P., Weisberg, F., Graham, J., McLeod, L., and Rosolowich, V. Mastalgia. J Obstet.Gynaecol.Can 2006;28(1):49-71. View abstract.
Sharpe, G. R. and Farr, P. M. Evening primrose oil and eczema. Lancet 3-17-1990;335(8690):667-668. View abstract.
Sharpe, G. R. and Farr, P. M. Evening primrose oil and eczema. Lancet 5-26-1990;335(8700):1283. View abstract.
Sholkens BA, Gehring D, Schlotte V, and et al. Evening Primrose oil, a dietary prostaglandin precursor diminishes vascular reactivity to resin and angiotensin II in rats. Prostagland Leukotrienes Med 1982;8:273-285.
Skogh, M. Atopic eczema unresponsive to evening primrose oil (linoleic and gamma- linolenic acids). J Am.Acad.Dermatol. 1986;15(1):114-115. View abstract.
Smith, R. L., Pruthi, S., and Fitzpatrick, L. A. Evaluation and management of breast pain. Mayo Clin Proc. 2004;79(3):353-372. View abstract.
Stonemetz, D. A review of the clinical efficacy of evening primrose. Holist.Nurs.Pract. 2008;22(3):171-174. View abstract.
Sture, G. H. and Lloyd, D. H. Canine atopic disease: therapeutic use of an evening primrose oil and fish oil combination. Vet.Rec. 8-12-1995;137(7):169-170. View abstract.
Swapan S, Sabyasachi B Nath GD. Evening primrose oil in treatment of atopic dermatitis: A randomized placebo-controlled trial. Indian Journal of Dermatology, Venereology and Leprology. 2008;(2)
Takahashi, R., Inoue, J., Ito, H., and Hibino, H. Evening primrose oil and fish oil in non-insulin-dependent-diabetes. Prostaglandins Leukot Essent Fatty Acids 1993;49(2):569-571. View abstract.
Tang W, Song YF He ZM. Clinical observation of Blackcurrant oil Soft Capsule and Evening primrose oil Soft Capsule in treating hyperlipidemia. Acta Chinese Medicine and Pharmacology 1993;21(4):37-38.
Taylor, M. Botanicals: medicines and menopause. Clin Obstet.Gynecol. 2001;44(4):853-863. View abstract.
Thuluvath PJ, Triger DR Manku MS Morse-Fisher N. Evening primrose oil in the treatment of severe refractory biliary pruritus. Eur J Gastroenterology and Hepatology 1991;3(1):87-90.
Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report of a therapeutic trial. Br Med J 1955;11:1041-1048.
Ty-Torredes, K. A. The effect of oral evening primrose oil on bishop score and cervical length amongst term gravidas. Am J Obstet Gynecol. 2006;195(6 Suppl 1):S30.
Uccella, R., Contini, A., and Sartorio, M. [Action of evening primrose oil on cardiovascular risk factors in insulin-dependent diabetics]. Clin Ter. 6-15-1989;129(5):381-388. View abstract.
van der Merwe, C. F. Booyens J. A double-blind placebo controlled trial of evening primrose oil (linoleic and gamma-linolenic acid) in primary liver cancer [EASL abstract]. J Hepatol. 1988;7(1):S189.
van Doormaal, J. J., Idema, I. G., Muskiet, F. A., Martini, I. A., and Doorenbos, H. Effects of short-term high dose intake of evening primrose oil on plasma and cellular fatty acid compositions, alpha-tocopherol levels, and erythropoiesis in normal and type 1 (insulin-dependent) diabetic men. Diabetologia 1988;31(8):576-584. View abstract.
Wade, V. A., Mansfield, P. R., and McDonald, P. J. Drug companies' evidence to justify advertising. Lancet 11-25-1989;2(8674):1261-1263. View abstract.
Wetzig, N. R. Mastalgia: a 3 year Australian study. Aust N Z J Surg 1994;64(5):329-331. View abstract.
Whelan, A. M., Jurgens, T. M., and Bowles, S. K. Natural health products in the prevention and treatment of osteoporosis: systematic review of randomized controlled trials. Ann Pharmacother 2006;40(5):836-849. View abstract.
Wolkin, A., Jordan, B., Peselow, E., Rubinstein, M., and Rotrosen, J. Essential fatty acid supplementation in tardive dyskinesia. Am J Psychiatry 1986;143(7):912-914. View abstract.
Woltil, H. A., van Beusekom, C. M., Schaafsma, A., Okken, A., and Muskiet, F. A. Does supplementation of formula with evening primrose and fish oils augment long chain polyunsaturated fatty acid status of low birthweight infants to that of breast-fed counterparts? Prostaglandins Leukot.Essent.Fatty Acids 1999;60(3):199-208. View abstract.
Wright, S. and Burton, J. L. Oral evening-primrose-seed oil improves atopic eczema. Lancet 11-20-1982;2(8308):1120-1122. View abstract.
Yoon, S., Lee, J., and Lee, S. The therapeutic effect of evening primrose oil in atopic dermatitis patients with dry scaly skin lesions is associated with the normalization of serum gamma-interferon levels. Skin Pharmacol Appl.Skin Physiol 2002;15(1):20-25. View abstract.
Abraham RD, Riemersma RA, Elton RA, et al. Effects of safflower oil and evening primrose oil in men with a low dihomo-gamma-linolenic level. Atherosclerosis 1990;81:199-208. View abstract.
Ahmad Adni LL, Norhayati MN, Mohd Rosli RR, Muhammad J. A Systematic Review and Meta-Analysis of the Efficacy of Evening Primrose Oil for Mastalgia Treatment. Int J Environ Res Public Health 2021;18(12):6295. View abstract.
Aman MG, Mitchell EA, Turbott SH. The effects of essential fatty acid supplementation by Efamol in hyperactive children. J Abnorm Child Psychol 1987;15:75-90. View abstract.
Ariana S, Amjadi N, Kazemi SN, Ahmadli Z. The Use of Evening Primrose Oil for Cervical Ripening in Low-Risk Women with Term Pregnancy: A Randomized Double-Blinded Controlled Trial. Complement Med Res 2024;31(3):215-221. View abstract.
Arnold LE, Kleykamp D, Votolato NA, et al. Gamma-linolenic acid for attention-deficit hyperactivity disorder: Placebo-controlled comparison to D-amphetamine. Biol Psychiatry 1989;25:222-8. View abstract.
Balci FL, Uras C, Feldman S. Clinical factors affecting the therapeutic efficacy of evening primrose oil on mastalgia. Ann Surg Oncol. 2020;27(12):4844-4852. Online ahead of print. View abstract.
Bassey EJ, Littlewood JJ, Rothwell MC, and Pye DW. Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women: two randomized controlled trials of Efacal v. calcium alone. Br J Nutr 2000;83(6):629-635. View abstract.
Behan PO, Behan WM, Horrobin D. Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurol Scand 1990;82:209-16. View abstract.
Belch J, Hill A. Evening primrose oil and borage oil in rheumatologic conditions. Am J Clin Nutr 2000;71:352S-6S. View abstract.
Belch JJ, Ansell D, Madhok R, et al. Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: A double blind placebo controlled study. Ann Rheum Dis 1988;47:96-104. View abstract.
Belch JJ, Shaw B, O'Dowd A, Saniabadi A, Leiberman P, Sturrock RD, and Forbes CD. Evening primrose oil (Efamol) in the treatment of Raynaud's phenomenon: a double blind study. Thromb.Haemost. 8-30-1985;54(2):490-494. View abstract.
Belch JJF, Shaw B, O'Dowd A, et al. Evening primrose oil (Efamol) as a treatment for cold-induced vasospasm (Raynaud's phenomenon). Prog Lipid Res 1986;25:335-40.
Bendich A. The potential for dietary supplements to reduce premenstrual syndrome (PMS) symptoms. J Am Coll Nutrition 2000;19:3-12. View abstract.
Berth-Jones J, Graham-Brown RA. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet 1993;341:1557-60. View abstract.
Biagi PL, Bordoni A, Hrelia S, et al. The effect of gamma-linolenic acid on clinical status, red cell fatty acid composition and membrane microviscosity in infants with atopic dermatitis. Drugs Exp Clin Res 1994;20:77-84. View abstract.
Blommers J, de Lange-De Klerk ES, Kuik DJ, et al. Evening primrose oil and fish oil for severe chronic mastalgia: a randomized, double-blind, controlled trial. Am J Obstet Gynecol 2002;187:1389-94.. View abstract.
Bordoni A, Biagi PL, Masi M, et al. Evening primrose oil (Efamol) in the treatment of children with atopic eczema. Drugs Exp Clin Res 1988;14:291-7. View abstract.
Brzeski M, Madhok R, and Capell HA. Evening primrose oil in patients with rheumatoid arthritis and side- effects of non-steroidal anti-inflammatory drugs. Br J Rheumatol 1991;30(5):370-372. View abstract.
Campbell ID, Stewart JCM, Royle GT, Taylor I. A randomized controlled trial of EPO for mastalgia. In: Mansel RE (ed). Recent Developments in the Study of Benign Breast Disease. The Proceedings of the 4th International Benign Breast Symposium. Manchester, England, April 1991. pg 89-96.
Cancelo Hidalgo MJ, Castelo-Branco C, Blumel JE, Lanchares Perez J.L, and Alvarez De Los Heros JI. Effect of a compound containing isoflavones, primrose oil and vitamin E in two different doses on climacteric symptoms. J Obstet Gynaecol 2006;26(4):344-347. View abstract.
Cant A, Shay J, Horrobin DF. The effect of maternal supplementation with linoleic and gamma- linolenic acids on the fat composition and content of human milk: a placebo-controlled trial. J Nutr Sci Vitaminol (Tokyo) 1991;37:573-9. View abstract.
Chalmers RJ and Shuster S. Evening primrose seed oil in ichthyosis vulgaris. Lancet 1-29-1983;1(8318):236-237. View abstract.
Chenoy R, Hussain S, Tayob Y, et al. Effect of oral gamolenic acid from evening primrose oil on menopausal flushing (abstract). BMJ 1994;308:501-3. View abstract.
Cheung KL. Management of cyclical mastalgia in oriental women: pioneer experience of using gamolenic acid (Efamast) in Asia. Aust N Z J Surg 1999;69:492-4.. View abstract.
Collins A, Cerin A, Coleman G, and Landgren BM. Essential fatty acids in the treatment of premenstrual syndrome. Obstet Gynecol 1993;81(1):93-98. View abstract.
D'Almeida A, Carter JP, Anatol A, Prost C. Effects of a combination of evening primrose oil (gamma linolenic acid) and fish oil (eicosapentaenoic + docahexaenoic acid) versus magnesium, and versus placebo in preventing pre-eclampsia. Women Health 1992;19:117-31. View abstract.
Das UN. The lipids that matter from infant nutrition to insulin resistance. Prostaglandins Leukot Essent Fatty Acids 2002;67:1-12. View abstract.
Dove D, Johnson P. Oral evening primrose oil: its effect on length of pregnancy and selected intrapartum outcomes in low-risk nulliparous women (abstract). J Nurse Midwifery 1999;44:320-4. View abstract.
Ebden P, Bevan C, Banks J, Fennerty A, and Walters EH. A study of evening primrose seed oil in atopic asthma. Prostaglandins Leukot Essent Fatty Acids 1989;35(2):69-72. View abstract.
Engler MM, Engler MB, Erickson SK, Paul SM. Dietary gamma-linolenic acid lowers blood pressure and alters aortic reactivity and cholesterol metabolism in hypertension. J Hypertens 1992;10:1197-204. View abstract.
Farzaneh F, Fatehi S, Sohrabi MR, Alizadeh K. The effect of oral evening primrose oil on menopausal hot flashes: a randomized clinical trial. Arch Gynecol Obstet 2013;288(5):1075-9.
Furse RK, Rossetti RG, Seiler CM, Zurier RB. Oral administration of gammalinolenic acid, an unsaturated fatty acid with anti-inflammatory properties, modulates interleukin-1beta production by human monocytes. J Clin Immunol 2002;22:83-91. View abstract.
Gehring W, Bopp R, Rippke F, and Gloor M. Effect of topically applied evening primrose oil on epidermal barrier function in atopic dermatitis as a function of vehicle. Arzneimittelforschung. 1999;49(7):635-642. View abstract.
Ghavi F, Shakeri F, Farahnaz H, Abdolahian S. Comparison of the Effect of Fennel and Evening Primrose Oil on Menopausal Problems and Hormonal Levels: A Randomized Controlled Trial. Iran J Nurs Midwifery Res 2023;28(4):430-435. View abstract.
Greenfield SM, Green AT, Teare JP, et al. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. Aliment Pharmacol Ther 1993;7:159-66. View abstract.
Guivernau M, Meza N, Barja P, Roman O. Clinical and experimental study on the long-term effect of dietary gamma-linolenic acid on plasma lipids, platelet aggregation, thromboxane formation, and prostacyclin production. Prostaglandins Leukot Essent Fatty Acids 1994;51:311-6. View abstract.
Gupta H, Pawar D, Riva A, et al. A randomized, double-blind, placebo-controlled trial to evaluate efficacy and tolerability of an optimized botanical combination in the management of patients with primary hypercholesterolemia and mixed dyslipidemia. Phytother Res 2012;26:265-272. View abstract.
Hansen TM, Lerche A, Kassis V, et al. Treatment of rheumatoid arthritis with prostaglandin E1 precursors cis-linoleic acid and gamma-linolenic acid. Scand J Rheumatol 1983;12:85-8. View abstract.
Hardy ML. Herbs of special interest to women. J Am Pharm Assoc 200;40:234-42. View abstract.
Hashemi H, Hasanpoor-Azghady SB, Farahani M, Amiri-Farahani L. Comparison of the effect of vaginal misoprostol and evening primrose oil capsule with misoprostol alone on the consequences of abortion in women with intrauterine fetal death: a randomized clinical trial. BMC Complement Med Ther 2023;23(1):248. View abstract.
Haslett C, Douglas JG, Chalmers SR, Weighhill A, and Munro JF. A double-blind evaluation of evening primrose oil as an antiobesity agent. Int.J Obes 1983;7(6):549-553. View abstract.
Head RJ, McLennan PL, Raederstorff D, et al. Prevention of nerve conduction deficit in diabetic rats by polyunsaturated fatty acids. Am J Clin Nutr 2000;71:386S-392S. View abstract.
Hederos CA, Berg A. Epogam evening primrose oil treatment in atopic dermatitis and asthma. Arch Dis Child 1996;75:494-7. View abstract.
Hemmatzadeh S, Mohammad Alizadeh Charandabi S, Veisy A, Mirghafourvand M. Evening primrose oil for cervical ripening in term pregnancies: a systematic review and meta-analysis. J Complement Integr Med 2021. View abstract.
Hoare, C., Li Wan, Po A., and Williams, H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000;4(37):1-191. View abstract.
Holman CP and Bell AF. A trial of evening primrose oil in the treatment of chronic schizophrenia. J Orhtomolecular Psych 1983;12:302-304.
Horner NK, Lampe JW. Potential mechanisms of diet therapy for fibrocystic breast conditions show inadequate evidence of effectiveness. J Am Diet Assoc 2000;100:1368-80. View abstract.
Horrobin DF. Evening primrose oil and premenstrual syndrome. Med J Aust 1990;153:630-1. View abstract.
Ishikawa T, Fujiyama Y, Igarashi O, Morino M, Tada N, Kagami A, Sakamoto T, Nagano M, and Nakamura H. Effects of gammalinolenic acid on plasma lipoproteins and apolipoproteins. Atherosclerosis 1989;75:95-104. View abstract.
Jaafarnejad F, Abidmoghaddam E, Emami SA, Saki A. Compare the effect of flaxseed, evening primrose oil, and Vitamin E on duration of periodic breast pain. J Educ Health Promot. 2017 Oct 4;6:85. View abstract.
Jalloh MA, Gregory PJ, Hein D, et al. Dietary supplement interactions with antiretrovirals: a systematic review. Int J STD AIDS. 2017 Jan;28(1):4-15. View abstract.
Jamal GA and Carmichael H. The effects of gamma-linolenic acid on human diabetic peripheral neuropathy: a double-blind placebo-controlled trial. Diabet Med 1990;7(4):319-323. View abstract.
Jamal GA. The use of gamma linolenic acid in the prevention and treatment of diabetic neuropathy. Diabet Med 1994;11:145-9. View abstract.
Jamilian M, Karamali M, ,Taghizadeh M, et al. Vitamin D and evening primrose oil administration improve glycemia and lipid profiles in women with gestational diabetes. Lipids. 2016 Mar;51(3):349-56. View abstract.
Jantti J, Seppala E, Vapaatalo H, and Isomaki H. Evening primrose oil and olive oil in treatment of rheumatoid arthritis. Clin Rheumatol 1989;8(2):238-244. View abstract.
Jenkins AP, Green AT, and Thompson RP. Essential fatty acid supplementation in chronic hepatitis B. Aliment Pharmacol Ther 1996;10(4):665-668. View abstract.
Kalati M, Kashanian M, Jahdi F, Naseri M, Haghani H, SHeikhansari N. Evening primrose oil and labour, is it effective? A randomized clinical trial. J Obstet Gynaecol. 2018 Feb 9:1-5. View abstract.
Kazemi F, Masoumi SZ, Shayan A, Oshvandi K. The Effect of Evening Primrose Oil Capsule on Hot Flashes and Night Sweats in Postmenopausal Women: A Single-Blind Randomized Controlled Trial. J Menopausal Med 2021;27(1):8-14. View abstract.
Kazmierska A, Boleslawska I, Polanska A, et al. Effect of Evening Primrose Oil Supplementation on Selected Parameters of Skin Condition in a Group of Patients Treated with Isotretinoin-A Randomized Double-Blind Trial. Nutrients 2022;14(14):2980. View abstract.
Keen H, Payan J, Allawi J, et al. Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group. Diabetes Care 1993;16:8-15. View abstract.
Kenny FS, Pinder SE, Ellis IO, et al. Gamma linolenic acid with tamoxifen as primary therapy in breast cancer. Int J Cancer 2000;85:643-8. View abstract.
Khoo SK, Munro C, Battistutta D. Evening primrose oil and treatment of premenstrual syndrome. Med J Aust 1990;153:189-92. View abstract.
Khorshidi M, Zarezadeh M, Moradi Moghaddam O, et al. Effect of evening primrose oil supplementation on lipid profile: a systematic review and meta-analysis of randomized clinical trials. Phytother Res. 2020;34(10):2628-2638. Online ahead of print. View abstract.
Kilic MO, Sen M, Icen D. The comparison of evening primrose oil, fructus agni casti, and reassurance in the treatment of mastalgia. Int J Surg Med. 2016;2(2):83-88.
Kleijnen J. Evening primrose oil. BMJ 1994;309:824-825. View abstract.
Kokke KH, Morris JA, and Lawrenson JG. Oral omega-6 essential fatty acid treatment in contact lens associated dry eye. Cont Lens Anterior Eye 2008;31(3):141-146. View abstract.
Kumari J, Amrita, Sinha A, Kumari S, Biswas P, Poonam. Effectiveness of Evening Primrose and Vitamin E for Cyclical Mastalgia: A Prospective Study. Cureus 2024;16(4):e58055. View abstract.
Kwon HS, Lee JH, Kim GM, Choi EH, Bae JM. Topical evening primrose oil as a possible therapeutic alternative in children with molluscum contagiosum. Clin Exp Dermatol. 2017 Dec;42(8):923-25. View abstract.
Laivuori H, Hovatta O, Viinikka L, et al. Dietary supplementation with primrose oil or fish oil does not change urinary excretion of prostacyclin and thromboxane metabolites in pre-eclamptic women. Prostaglandins Leukot Essent Fatty Acids 1993;49:691-4. View abstract.
Liang XC and Guo SS. [Effect of jiang-zhi zhong-yao-pian on total cholesterol, triglyceride, TXB2, 6-keto-PGF1 alpha in hyperlipemic patients]. Zhong Xi Yi Jie He Za Zhi 1991;11:20-2, 4. View abstract.
Lindmark L and Clough P. A 5-month open study with long-chain polyunsaturated fatty acids in dyslexia. J Med Food 2007;10(4):662-6. View abstract.
Lovell CR, Burton JL, and Horrobin DF. Treatment of atopic eczema with evening primrose oil. Lancet 1-31-1981;1(8214):278. View abstract.
Mahmoodinasab M, Loripoor M, Vazirinejad R, Aminzadeh F. Effect of misoprostol with and without evening primrose (Oenothera biennis) on induction of missed abortion. Avicenna J Phytomed 2023;13(5):454-462. View abstract.
Makrides M, Neumann M, Simmer K, Pater J, and Gibson R. Are long-chain polyunsaturated fatty acids essential nutrients in infancy? Lancet 1995;345(8963):1463-1468. View abstract.
Mansel RE, Pye JK Hughes LE. Effects of essential fatty acids on cyclical mastalgia and non-cyclical breast disorders. In: Horrobin DF. Omega-6 essential fatty acids: pathophysiology and roles in clinical medicine. New York: Wiley-Liss;1990.
Mansour Ghanaei M, Asgharnia M, Farokhfar M, Mohammad Asgari Ghalebin S, Rafiei E, Haryalchi K. The effect of consuming evening primrose oil on cervical preparation before hysteroscopy: An RCT. Int J Reprod Biomed 2022;20(7):591-600. View abstract.
McKendry RJ. Treatment of Sjogren's syndrome with essential fatty acids, pyridoxine and vitamin C. Prostaglandins Leukot Med 1982;8:403-8. View abstract.
Menendez JA, Colomer R, Lupu R. Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3n-6) is a selective estrogen-response modulator in human breast cancer cells: gamma-Linolenic acid antagonizes estrogen receptor-dependent transcriptional activity, transcriptionally represses estrogen receptor expression and synergistically enhances tamoxifen and ICI 182,780 (Faslodex) efficacy in human breast cancer cells. Int J Cancer 2004;10;109:949-54. View abstract.
Menendez JA, del Mar Barbacid M, Montero S, et al. Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells. Eur J Cancer 2001;37:402-13. View abstract.
Moghadam MY, Nemat-Shahi M, Soroosh D, Nemat-Shahi M, Asadi A. Effect of evening primrose oil on postoperative pain after appendectomy: A double-blind, randomized, clinical trial. Biomedicine (Taipei) 2020;10(1):28-32. View abstract.
Veselinovic M, Vasiljevic D, Vucic V, et al. Clinical benefits of n-3 PUFA and gamma-Linolenic acid in patients with rheumatoid arthritis. Nutrients. 2017 Mar 25;9(4). View abstract.
Viikari J and Lehtonen A. Effect of primrose oil on serum lipids and blood pressure in hyperlipidemic subjects. Int J Clin Pharmacol Ther Toxicol 1986;2:668-670. View abstract.
Warren G, McKendrick M, Peet M. The role of essential fatty acids in chronic fatigue syndrome. A case-controlled study of red-cell membrane essential fatty acids (EFA) and a placebo-controlled treatment study with high dose of EFA. Acta Neurol Scand 1999;99:112-6. View abstract.
Wedig KE, Whitsett JA. Down the primrose path: petechiae in a neonate exposed to herbal remedy for parturition. J Pediatr 2008;152:140, 140.e1. View abstract.
Whitaker DK, Cilliers J, de Beer C. Evening primrose oil (Epogam) in the treatment of chronic hand dermatitis: disappointing therapeutic results. Dermatology 1996;193:115-20. View abstract.
Williams HC. Evening primrose oil for atopic dermatitis. BMJ 2003;327:1358-9. View abstract.
Wright S. Atopic dermatitis and essential fatty acids: a biochemical basis for atopy? Acta Derm Venereol Suppl (Stockh) 1985;114:143-145. View abstract.
Zou L, Harkey MR, and Henderson GL. Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity. Life Sci 8-16-2002;71(13):1579-1589. View abstract.
Select a condition to view a list of vitamins
CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.
This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2024 by Therapeutic Research Center, LLC. All Rights Reserved.